Significant fluctuations are estimated for all segments over the forecast period for the revenue. In general, the indicator appears to exhibit a positive trend, with more segments showing increasing values rather than decreasing values until 2028. Among them, the segment Oncology Drugs attains the highest value throughout the entire period, reaching 8.7 billion U.S. dollars.
Revenue in the Pharmaceuticals market for different segments France from 2017 to 2028 (in million U.S. dollars)
Other statistics that may interest you Novartis
Overview
6
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2023
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2024
- Basic Statistic Gross margin ranking of top pharmaceutical companies 2022
- Premium Statistic Pharmaceutical companies - revenue from top 3 products 2023
- Premium Statistic Top therapy classes by spending global market 2027 forecast
Financials
5
Segments
4
Competitors
6
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
- Premium Statistic Pfizer's total revenue 2006-2023
- Premium Statistic Merck & Co - total revenue 2006-2023
- Premium Statistic Johnson & Johnson's total sales 2005-2023
- Basic Statistic AbbVie's revenue 2010-2023
- Premium Statistic Roche Group's total sales 2006-2023
Research and development
4
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Premium Statistic Novartis' expenditure on research and development 2004-2023
- Premium Statistic Novartis' R&D expenditure as a percent of revenue 2004-2023
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
Outlook
4
- Premium Statistic Sales forecast of select blockbuster drugs by Novartis worldwide 2028
- Basic Statistic Sales forecast of select Novartis R&D projects worldwide 2028
- Premium Statistic Top pharma companies by cardio revenue worldwide 2023 and 2028
- Basic Statistic AI readiness of big pharma companies 2023
Further Content: You might find this interesting as well
Statista Market Insights. (December 18, 2023). Revenue in the Pharmaceuticals market for different segments France from 2017 to 2028 (in million U.S. dollars) [Graph]. In Statista. Retrieved June 30, 2024, from https://www.statista.com/forecasts/1443458/revenue-pharmaceuticals-market-for-different-segments-france
Statista Market Insights. "Revenue in the Pharmaceuticals market for different segments France from 2017 to 2028 (in million U.S. dollars)." Chart. December 18, 2023. Statista. Accessed June 30, 2024. https://www.statista.com/forecasts/1443458/revenue-pharmaceuticals-market-for-different-segments-france
Statista Market Insights. (2023). Revenue in the Pharmaceuticals market for different segments France from 2017 to 2028 (in million U.S. dollars). Statista. Statista Inc.. Accessed: June 30, 2024. https://www.statista.com/forecasts/1443458/revenue-pharmaceuticals-market-for-different-segments-france
Statista Market Insights. "Revenue in The Pharmaceuticals Market for Different Segments France from 2017 to 2028 (in Million U.S. Dollars)." Statista, Statista Inc., 18 Dec 2023, https://www.statista.com/forecasts/1443458/revenue-pharmaceuticals-market-for-different-segments-france
Statista Market Insights, Revenue in the Pharmaceuticals market for different segments France from 2017 to 2028 (in million U.S. dollars) Statista, https://www.statista.com/forecasts/1443458/revenue-pharmaceuticals-market-for-different-segments-france (last visited June 30, 2024)
Revenue in the Pharmaceuticals market for different segments France from 2017 to 2028 (in million U.S. dollars) [Graph], Statista Market Insights, December 18, 2023. [Online]. Available: https://www.statista.com/forecasts/1443458/revenue-pharmaceuticals-market-for-different-segments-france